Pharmacists should continue to emphasize the vaccine’s effectiveness in preventing cancer and be prepared to address patient safety concerns.
Caitlyn V. Bradford, PharmD, BCPPS
Advertisement
Articles by Caitlyn V. Bradford, PharmD, BCPPS
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Advertisement
Latest Updated Articles
HPV Vaccine: Balancing Benefits, Risks, and Public PerceptionPublished: May 19th 2025 | Updated:
Combating Advancing Cancers With CAR T-Cell TherapyPublished: September 8th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5
